ZyVersa Therapeutics Inc Sustainability Reports
ZyVersa Therapeutics, Inc. is a clinical-stage biopharmaceutical company that leverages proprietary technologies to develop first-in-class prescription drugs. The company focuses on the development and commercialization of product candidates treating renal and inflammatory diseases.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
FIGI: BBG01137LQD2
3 reports from 2022 to 2024